|
chr4_-_57976550
|
3.037
|
NM_001253835
NM_001553
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
chr11_+_129939792
|
2.617
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr6_+_148663953
|
2.520
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr11_+_129939807
|
2.425
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr11_+_129939787
|
2.419
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr16_+_55515468
|
2.224
|
NM_001127891
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
|
|
chr6_+_148663728
|
2.206
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr7_-_47621635
|
2.196
|
|
TNS3
|
tensin 3
|
|
chr11_+_129939667
|
2.184
|
NM_001142276
NM_001142277
NM_001142278
NM_001642
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr1_-_94702916
|
2.118
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
chr17_-_74707000
|
2.038
|
NM_001008528
NM_001008529
NM_198530
|
MXRA7
|
matrix-remodelling associated 7
|
|
chr7_-_47621741
|
2.035
|
NM_022748
|
TNS3
|
tensin 3
|
|
chr6_+_7541837
|
2.008
|
|
DSP
|
desmoplakin
|
|
chr6_+_7541892
|
1.981
|
|
DSP
|
desmoplakin
|
|
chr2_-_1748317
|
1.948
|
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chr19_+_45349560
|
1.920
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr6_+_7541863
|
1.880
|
NM_001008844
NM_004415
|
DSP
|
desmoplakin
|
|
chr4_-_122618098
|
1.860
|
|
ANXA5
|
annexin A5
|
|
chr1_-_94703252
|
1.844
|
NM_004815
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
chr12_-_124457099
|
1.840
|
NM_025140
|
CCDC92
|
coiled-coil domain containing 92
|
|
chr2_-_175869910
|
1.830
|
NM_001822
NM_001025201
|
CHN1
|
chimerin (chimaerin) 1
|
|
chr17_+_79651035
|
1.803
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr4_-_122618129
|
1.722
|
|
ANXA5
|
annexin A5
|
|
chr18_+_55711890
|
1.701
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr10_+_115438934
|
1.682
|
NM_033340
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
chr4_-_122618140
|
1.677
|
NM_001154
|
ANXA5
|
annexin A5
|
|
chr8_-_17658385
|
1.667
|
NM_001001924
NM_001001925
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
chr6_+_17393610
|
1.638
|
NM_006366
|
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast)
|
|
chr9_+_123963728
|
1.601
|
|
GSN
|
gelsolin
|
|
chr21_+_42540054
|
1.591
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
chr21_+_42540092
|
1.589
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
chr13_+_110959592
|
1.573
|
NM_001846
|
COL4A2
|
collagen, type IV, alpha 2
|
|
chr6_-_47277354
|
1.563
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr16_+_82660573
|
1.552
|
|
CDH13
|
cadherin 13, H-cadherin (heart)
|
|
chr16_+_56659584
|
1.520
|
NM_175617
|
MT1E
|
metallothionein 1E
|
|
chr9_-_99382073
|
1.516
|
NM_003671
NM_033331
|
CDC14B
|
CDC14 cell division cycle 14 homolog B (S. cerevisiae)
|
|
chr5_-_122372413
|
1.511
|
NM_000943
|
PPIC
|
peptidylprolyl isomerase C (cyclophilin C)
|
|
chr11_+_129939847
|
1.505
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr6_+_148664124
|
1.489
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr11_+_832965
|
1.444
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
chr13_-_110959441
|
1.441
|
NM_001845
|
COL4A1
|
collagen, type IV, alpha 1
|
|
chr17_-_3571905
|
1.435
|
NM_001204698
NM_014604
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
chr11_-_116708334
|
1.430
|
NM_000039
|
APOA1
|
apolipoprotein A-I
|
|
chr15_-_52587851
|
1.429
|
NM_018728
|
MYO5C
|
myosin VC
|
|
chr5_+_150400132
|
1.417
|
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr2_-_1748240
|
1.410
|
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chrX_+_117861523
|
1.406
|
NM_001560
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
chr18_+_55711746
|
1.388
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr18_+_55711388
|
1.381
|
NM_001144967
NM_001243960
NM_015277
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr6_-_47277246
|
1.355
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr17_+_79650961
|
1.352
|
NM_004712
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr17_+_79651042
|
1.345
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr11_-_82611358
|
1.328
|
NM_005040
NM_199418
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
chr9_+_706744
|
1.317
|
NM_153186
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
chr16_+_66400524
|
1.306
|
NM_001795
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
chr22_-_19929447
|
1.300
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr9_-_74383301
|
1.298
|
NM_001135820
NM_013390
|
TMEM2
|
transmembrane protein 2
|
|
chr19_-_18717631
|
1.276
|
NM_004750
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr19_-_18717467
|
1.268
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr19_-_18717577
|
1.262
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr6_-_52441714
|
1.258
|
|
TRAM2
|
translocation associated membrane protein 2
|
|
chr19_+_15218141
|
1.252
|
NM_033025
|
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
|
|
chr2_-_1748285
|
1.251
|
NM_012293
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chr6_+_107811272
|
1.245
|
NM_018013
|
SOBP
|
sine oculis binding protein homolog (Drosophila)
|
|
chr10_-_126849556
|
1.244
|
NM_001083914
|
CTBP2
|
C-terminal binding protein 2
|
|
chr14_-_69445772
|
1.236
|
|
ACTN1
|
actinin, alpha 1
|
|
chr22_-_19929333
|
1.228
|
NM_006440
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr9_+_137533643
|
1.211
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
|
chr14_+_105941061
|
1.186
|
NM_001312
|
CRIP2
|
cysteine-rich protein 2
|
|
chr6_+_142622797
|
1.181
|
NM_001032394
NM_001032395
NM_020455
NM_198569
|
GPR126
|
G protein-coupled receptor 126
|
|
chr17_-_3571819
|
1.179
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
chr22_+_38142316
|
1.171
|
|
TRIOBP
|
TRIO and F-actin binding protein
|
|
chr11_-_2162340
|
1.169
|
NM_001127598
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
|
chr9_-_84303595
|
1.169
|
NM_005077
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
chr3_+_52529351
|
1.167
|
NM_015136
|
STAB1
|
stabilin 1
|
|
chr17_-_74707066
|
1.166
|
|
MXRA7
|
matrix-remodelling associated 7
|
|
chr2_-_224903933
|
1.163
|
NM_001136528
NM_006216
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
chr2_-_216300770
|
1.162
|
NM_002026
NM_054034
NM_212474
NM_212476
NM_212478
NM_212482
|
FN1
|
fibronectin 1
|
|
chr11_-_63381940
|
1.157
|
NM_001128203
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr5_+_176513819
|
1.155
|
NM_002011
NM_213647
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
chr1_+_151512760
|
1.134
|
NM_001126337
NM_020127
|
TUFT1
|
tuftelin 1
|
|
chr17_+_79651072
|
1.133
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr10_-_62703822
|
1.128
|
NM_001242359
NM_014836
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
|
chr6_-_52441815
|
1.124
|
NM_012288
|
TRAM2
|
translocation associated membrane protein 2
|
|
chr11_-_63381840
|
1.114
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr20_-_61569227
|
1.110
|
|
DIDO1
|
death inducer-obliterator 1
|
|
chr3_+_171757413
|
1.097
|
NM_022763
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
chr22_+_38142255
|
1.087
|
|
TRIOBP
|
TRIO and F-actin binding protein
|
|
chr11_-_63381485
|
1.083
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr11_-_63381907
|
1.082
|
NM_007069
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr17_-_7297826
|
1.082
|
|
PLSCR3
|
phospholipid scramblase 3
|
|
chr5_+_150399980
|
1.078
|
NM_002084
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr13_-_103451271
|
1.061
|
NM_024089
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1
|
|
chr22_-_19929250
|
1.057
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr19_-_4400470
|
1.055
|
NM_001199943
NM_003025
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
chr8_+_38854524
|
1.045
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
chr9_+_97488943
|
1.038
|
NM_001193331
NM_032823
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr19_+_45349584
|
1.020
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr3_+_52489617
|
1.014
|
|
NISCH
|
nischarin
|
|
chr9_+_97488993
|
1.006
|
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr22_+_44319685
|
0.995
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr3_+_52529370
|
0.992
|
|
STAB1
|
stabilin 1
|
|
chr7_-_30029284
|
0.979
|
NM_001145515
NM_014766
NM_001145513
|
SCRN1
|
secernin 1
|
|
chr8_+_38854431
|
0.975
|
NM_003816
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
chr7_+_45927958
|
0.972
|
NM_000596
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
chr4_+_4861371
|
0.965
|
NM_002448
|
MSX1
|
msh homeobox 1
|
|
chr22_+_44319674
|
0.960
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr21_+_46825291
|
0.958
|
|
|
|
|
chrX_-_51239295
|
0.958
|
|
NUDT11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11
|
|
chr7_+_94139331
|
0.956
|
|
CASD1
|
CAS1 domain containing 1
|
|
chr22_+_38302296
|
0.948
|
|
MICALL1
|
MICAL-like 1
|
|
chr16_+_8768403
|
0.946
|
NM_020686
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
chr22_+_44319618
|
0.942
|
NM_025225
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr22_+_38142230
|
0.932
|
NM_007032
NM_138632
|
TRIOBP
|
TRIO and F-actin binding protein
|
|
chr12_-_122326516
|
0.927
|
NM_001171993
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase
|
|
chr19_+_42829760
|
0.922
|
NM_001410
|
MEGF8
|
multiple EGF-like-domains 8
|
|
chr19_+_676346
|
0.919
|
NM_005860
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
chr19_+_35532640
|
0.908
|
|
HPN
|
hepsin
|
|
chr2_+_85360373
|
0.903
|
NM_031283
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
|
chr17_-_48264039
|
0.891
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
chr19_-_4400357
|
0.888
|
NM_001199944
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
chr1_+_17944810
|
0.882
|
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like
|
|
chr19_+_50016490
|
0.872
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr12_+_52345437
|
0.866
|
NM_004302
NM_020328
|
ACVR1B
|
activin A receptor, type IB
|
|
chr5_-_1112106
|
0.862
|
NM_006598
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporters), member 7
|
|
chr19_+_35550794
|
0.862
|
|
HPN
|
hepsin
|
|
chr2_-_110371669
|
0.855
|
NM_144710
NM_178584
|
SEPT10
|
septin 10
|
|
chr4_-_41216455
|
0.849
|
NM_001166050
NM_004307
NM_173075
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
chr11_+_68079999
|
0.849
|
NM_002335
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
chr19_+_35532617
|
0.840
|
|
HPN
|
hepsin
|
|
chr19_+_50016435
|
0.828
|
NM_004107
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr7_+_94138991
|
0.823
|
NM_022900
|
CASD1
|
CAS1 domain containing 1
|
|
chr17_-_78194085
|
0.817
|
NM_000199
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
chr4_+_184020343
|
0.809
|
NM_024949
|
WWC2
|
WW and C2 domain containing 2
|
|
chr22_+_29702950
|
0.802
|
NM_006478
NM_152236
NM_152237
|
GAS2L1
|
growth arrest-specific 2 like 1
|
|
chr19_-_11373117
|
0.801
|
NM_020812
|
DOCK6
|
dedicator of cytokinesis 6
|
|
chr21_+_18885104
|
0.797
|
NM_001207063
NM_001207064
NM_001207065
NM_001207066
NM_001338
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
chr2_+_36583369
|
0.795
|
NM_016441
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
chr9_-_13279562
|
0.795
|
|
MPDZ
|
multiple PDZ domain protein
|
|
chr21_+_18885296
|
0.793
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
chr15_+_33010174
|
0.787
|
NM_001191322
NM_001191323
NM_013372
|
GREM1
|
gremlin 1
|
|
chr7_+_143079354
|
0.785
|
|
ZYX
|
zyxin
|
|
chr9_-_140083010
|
0.784
|
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
chr16_+_56659679
|
0.783
|
|
MT1E
|
metallothionein 1E
|
|
chr9_+_112810877
|
0.783
|
NM_001004065
NM_001198656
|
AKAP2
|
A kinase (PRKA) anchor protein 2
|
|
chr13_+_98795410
|
0.775
|
NM_001001715
NM_005766
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
|
chr22_-_37915209
|
0.774
|
NM_014550
|
CARD10
|
caspase recruitment domain family, member 10
|
|
chr12_+_66218879
|
0.760
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
chr2_+_219646448
|
0.758
|
NM_000784
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
chr2_-_242447919
|
0.754
|
|
STK25
|
serine/threonine kinase 25
|
|
chr9_-_14313509
|
0.751
|
|
NFIB
|
nuclear factor I/B
|
|
chr1_-_68299047
|
0.732
|
NM_018841
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
chr10_+_75670861
|
0.732
|
NM_001145031
NM_002658
|
PLAU
|
plasminogen activator, urokinase
|
|
chrX_+_135229536
|
0.731
|
NM_001159702
NM_001159703
NM_001449
|
FHL1
|
four and a half LIM domains 1
|
|
chr17_+_74380943
|
0.730
|
|
SPHK1
|
sphingosine kinase 1
|
|
chr16_-_122573
|
0.724
|
NM_022450
|
RHBDF1
|
rhomboid 5 homolog 1 (Drosophila)
|
|
chr20_-_23618382
|
0.723
|
NM_000099
|
CST3
|
cystatin C
|
|
chr3_-_81810816
|
0.718
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
chr1_-_201476248
|
0.718
|
NM_001193570
NM_004078
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr4_-_89080010
|
0.712
|
NM_004827
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2
|
|
chr11_+_833007
|
0.710
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
chr6_-_47277511
|
0.709
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr1_+_19923457
|
0.709
|
NM_001204088
NM_001204089
NM_001032363
NM_001204082
NM_001204083
|
C1orf151-NBL1
MINOS1
|
C1orf151-NBL1 readthrough
mitochondrial inner membrane organizing system 1
|
|
chr1_-_201476241
|
0.708
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr19_+_50016500
|
0.706
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr12_-_106533810
|
0.703
|
NM_014840
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
chr2_+_110371887
|
0.701
|
NM_023016
|
ANKRD57
|
ankyrin repeat domain 57
|
|
chr17_+_75136985
|
0.697
|
NM_001039573
NM_001143998
NM_001143999
NM_003003
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae)
|
|
chr1_+_77748286
|
0.697
|
NM_012093
|
AK5
|
adenylate kinase 5
|
|
chr4_-_157892545
|
0.695
|
NM_016205
|
PDGFC
|
platelet derived growth factor C
|
|
chr16_+_82660390
|
0.695
|
NM_001220488
NM_001220489
NM_001220490
NM_001220491
NM_001220492
NM_001257
|
CDH13
|
cadherin 13, H-cadherin (heart)
|
|
chr13_+_113741668
|
0.689
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr3_-_81810618
|
0.684
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
chr1_-_209979388
|
0.683
|
NM_001206696
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
|
chr2_-_20850822
|
0.680
|
NM_022460
|
HS1BP3
|
HCLS1 binding protein 3
|
|
chr1_-_27240430
|
0.679
|
NM_021969
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
chr2_-_242448000
|
0.676
|
NM_006374
|
STK25
|
serine/threonine kinase 25
|
|
chr1_-_201476218
|
0.673
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr13_-_37633568
|
0.671
|
NM_001014286
NM_017569
|
FAM48A
|
family with sequence similarity 48, member A
|
|
chr19_-_44124013
|
0.666
|
NM_182498
|
ZNF428
|
zinc finger protein 428
|
|
chr13_+_113622758
|
0.664
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr17_-_37381920
|
0.658
|
NM_198993
|
STAC2
|
SH3 and cysteine rich domain 2
|
|
chr17_+_74381419
|
0.655
|
|
SPHK1
|
sphingosine kinase 1
|
|
chr1_-_201475966
|
0.654
|
NM_001193571
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr2_+_182756468
|
0.650
|
NM_001130445
NM_006751
|
SSFA2
|
sperm specific antigen 2
|
|
chr9_-_16870664
|
0.648
|
|
BNC2
|
basonuclin 2
|
|
chr6_-_47277646
|
0.646
|
NM_014452
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr2_-_242447449
|
0.645
|
|
STK25
|
serine/threonine kinase 25
|
|
chr19_-_44123732
|
0.641
|
|
ZNF428
|
zinc finger protein 428
|
|
chr2_+_219283809
|
0.639
|
NM_007127
|
VIL1
|
villin 1
|
|
chr11_+_832909
|
0.636
|
NM_001039490
NM_004357
NM_139029
NM_139030
|
CD151
|
CD151 molecule (Raph blood group)
|
|
chr1_-_95392501
|
0.633
|
NM_001839
|
CNN3
|
calponin 3, acidic
|
|
chr22_-_36783977
|
0.632
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
chr22_-_36783851
|
0.624
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
chr20_-_23030141
|
0.620
|
NM_000361
|
THBD
|
thrombomodulin
|
|
chr22_+_38597938
|
0.619
|
NM_001161572
NM_001161574
NM_012323
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr17_+_79651052
|
0.616
|
|
|
|
|
chr14_+_96505566
|
0.610
|
NM_001252507
|
C14orf132
|
chromosome 14 open reading frame 132
|
|
chr8_-_13134028
|
0.609
|
|
DLC1
|
deleted in liver cancer 1
|
|
chr9_-_140083034
|
0.608
|
NM_013366
|
ANAPC2
|
anaphase promoting complex subunit 2
|
